Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia

Hematology Oncology Associates of Fredericksburg Inc is a clinical research site located in Fredericksburg, Virginia, United States 22408.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Hematology Oncology Associates of Fredericksburg Inc has participated in 46 clinical trials with 27 currently active.

Therapeutic areas: Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Associates of Fredericksburg Inc?

Hematology Oncology Associates of Fredericksburg Inc has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Associates of Fredericksburg Inc conducted?

Hematology Oncology Associates of Fredericksburg Inc has 46 clinical trials on record, with 27 currently active. Their work covers Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Is Hematology Oncology Associates of Fredericksburg Inc accredited by Crixeo Health?

Yes — Hematology Oncology Associates of Fredericksburg Inc holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hematology Oncology Associates of Fredericksburg Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.